Markets Gone Wild

NYLI MacKay DefinedTerm Muni Opportunities Fund Announces Consistent Monthly Dividend NEW YORK–(Business Wire)–NYLI MacKay DefinedTerm Muni Opportunities Fund (the “Fund”) (NYSE:MMD) has announced its monthly dividend distribution for common shareholders. The dividend amount of $0.06 per share remains unchanged from the previous month’s distribution. Consistent Dividend Distribution The Fund’s consistent dividend distribution reflects the performance…

Welcome to Richardson Electronics, Ltd. Q1 2025 Earnings Call Transcript Key Players During the earnings call, important figures from Richardson Electronics, Ltd. were present: Ed Richardson – CEO Bob Ben – CFO Greg Peloquin – GM, Power & Microwave Technologies Group, Green Energy Solutions Wendy Diddell – COO & GM for Richardson Healthcare Jens Ruppert…

Unleashing the Power of Zacks Style Scores for Selecting High-Performing Stocks Investing in the stock market can be an exciting and profitable endeavor, but it also comes with its fair share of risks and uncertainties. One effective way to mitigate these risks and increase the chances of picking strong, market-beating stocks for your investment portfolio…

The Rise and Fall of MRNA Stock: An Analysis Introduction During the COVID-19 pandemic, Moderna’s stock (MRNA) experienced an astonishing surge of 4,211%. Investors flocked to the biotech company as it raced to develop a vaccine against the deadly virus. However, since then, MRNA’s stock price has plummeted to $31, reflecting a significant bubble and…

Bronstein, Gewirtz & Grossman, LLC Investigates Potential Securities Fraud Class Action against Septerna, Inc. NEW YORK, NY – March 3, 2025 Have you been keeping up with the latest happenings in the stock market? If you’ve got some Septerna, Inc. (Septerna or the Company) (NASDAQ:SEPN) shares in your portfolio, buckle up, because things are getting…

Important Information for Regeneron Pharmaceuticals Securities Buyers: Rosen Law Firm Reminds of Upcoming Deadline New York, NY – In a recent press release on February 10, 2025, Rosen Law Firm, a renowned global investor rights law firm, reminded investors who purchased securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023, and October 30,…